1. Home
  2. NVCR vs ARRY Comparison

NVCR vs ARRY Comparison

Compare NVCR & ARRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCR
  • ARRY
  • Stock Information
  • Founded
  • NVCR 2000
  • ARRY 1989
  • Country
  • NVCR Switzerland
  • ARRY United States
  • Employees
  • NVCR N/A
  • ARRY N/A
  • Industry
  • NVCR Medical/Dental Instruments
  • ARRY Semiconductors
  • Sector
  • NVCR Health Care
  • ARRY Technology
  • Exchange
  • NVCR Nasdaq
  • ARRY Nasdaq
  • Market Cap
  • NVCR 1.3B
  • ARRY 1.3B
  • IPO Year
  • NVCR 2015
  • ARRY 2020
  • Fundamental
  • Price
  • NVCR $11.25
  • ARRY $7.60
  • Analyst Decision
  • NVCR Buy
  • ARRY Buy
  • Analyst Count
  • NVCR 7
  • ARRY 20
  • Target Price
  • NVCR $28.64
  • ARRY $10.38
  • AVG Volume (30 Days)
  • NVCR 1.5M
  • ARRY 7.1M
  • Earning Date
  • NVCR 10-30-2025
  • ARRY 11-05-2025
  • Dividend Yield
  • NVCR N/A
  • ARRY N/A
  • EPS Growth
  • NVCR N/A
  • ARRY N/A
  • EPS
  • NVCR N/A
  • ARRY N/A
  • Revenue
  • NVCR $642,269,000.00
  • ARRY $1,333,329,000.00
  • Revenue This Year
  • NVCR $9.54
  • ARRY $34.42
  • Revenue Next Year
  • NVCR $5.70
  • ARRY $14.70
  • P/E Ratio
  • NVCR N/A
  • ARRY N/A
  • Revenue Growth
  • NVCR 11.17
  • ARRY 35.75
  • 52 Week Low
  • NVCR $10.70
  • ARRY $3.76
  • 52 Week High
  • NVCR $34.13
  • ARRY $10.37
  • Technical
  • Relative Strength Index (RSI)
  • NVCR 35.05
  • ARRY 41.97
  • Support Level
  • NVCR $10.70
  • ARRY $7.34
  • Resistance Level
  • NVCR $12.01
  • ARRY $8.46
  • Average True Range (ATR)
  • NVCR 0.57
  • ARRY 0.73
  • MACD
  • NVCR -0.11
  • ARRY -0.11
  • Stochastic Oscillator
  • NVCR 15.48
  • ARRY 13.17

About NVCR NovoCure Limited

NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

About ARRY Array Technologies Inc.

Array Technologies Inc manufacturer of ground-mounting systems used in solar energy projects. The company's segments include: the Array legacy operating segment (Array Legacy Operations) and the STI Operations operating segment (STI Operations). It derives maximum revenue from the Array legacy operating segment. Its product is an integrated system of steel supports, electric motors, gearboxes and electronic controllers referred to as a single-axis tracker that move solar panels throughout the day to maintain an optimal orientation to the sun, which increases their energy production. Geographically, the company's operations are in the United States, Australia, Spain, Brazil and Rest of the World with the United States deriving the majority of the revenue.

Share on Social Networks: